719
edits
🛈 Note: policy and procedure locations have changed.
For CAHP policies and procedures, please refer to the UNMC catalog.
For program-specific policies and procedures, please refer to the Program-Specific Handbooks.
Cardiovascular Interventional Technology: Difference between revisions
Jump to navigation
Jump to search
Cardiovascular Interventional Technology (view source)
Revision as of 14:50, October 19, 2016
, October 19, 2016→ALARA DOSE LIMITS (PER MONITORING PERIOD)
| Line 116: | Line 116: | ||
The Radiation Safety Committee may alter these values based on regulatory or departmental concerns. When an individual exceeds any one of these levels, a follow-up survey may be conducted to determine if a reduction in dose can be reasonably achieved. | The Radiation Safety Committee may alter these values based on regulatory or departmental concerns. When an individual exceeds any one of these levels, a follow-up survey may be conducted to determine if a reduction in dose can be reasonably achieved. | ||
For further information regarding personnel monitoring of ionizing radiation, refer to the UNMC [http://www.unmc.edu/ | For further information regarding personnel monitoring of ionizing radiation, refer to the UNMC [http://www.unmc.edu/ehs/radiation-safety/radiation-manual.html Radiation Safety Manual] or contact the Radiation Safety Office. | ||
Students are responsible for bioassays for the presence of I-125 or I-131 in the thyroid at appropriate times during their clinical experiences (Nuclear Medicine Technology). | Students are responsible for bioassays for the presence of I-125 or I-131 in the thyroid at appropriate times during their clinical experiences (Nuclear Medicine Technology). | ||